Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid-Reference-Cited by-同舟云学术

Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid

Published:1995-04 Issue:4 Volume:21 Page:929-932
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Durand François,Bernuau Jacques,Pessayre Dominique,Samuel Didier,Belaiche Jacques,Degott Claude,Bismuth Henri,Belghiti Jacques,Erlinger Serge,Rueff Bernard,Benhamou Jean Pierre

Publisher

Wiley

Subject

Hepatology

Reference18 articles.

1. The New Tuberculosis

2. Treating Tuberculosis: What Drugs, for How Long?

3. . Fulminant and subfulminant liver failure. In: , , , , eds. Oxford textbook of clinical hepatology. Vol 2. Oxford, UK: Oxford University Press, 1991: 923–942.

4. Isoniazid-Rifampin Fulminant Hepatitis

5. Toxic Hepatitis with Isoniazid and Rifampin

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity;Pharmacogenomics;2024-04-12

2. Delphi Survey on the Current and Future Korean Guidelines for Isoniazid-Monoresistant Tuberculosis;Infection and Drug Resistance;2023-08

3. Side Effects of TB Therapy and Recent Therapeutic Approaches for Tuberculosis Management;Asian Journal of Pharmaceutical Research;2023-03-22

4. Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment—A Study from Patients of Portuguese Health Centers;Journal of Personalized Medicine;2022-05-13

5. Adverse drug reactions in tuberculosis and management;Indian Journal of Tuberculosis;2019-10